ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Frontier Pharma Limited

Frontier Pharma Limited is an active company incorporated on 18 April 2016 with the registered office located in Wokingham, Berkshire. Frontier Pharma Limited was registered 9 years ago.
Status
Active
Active since incorporation
Company No
10130529
Private limited company
Age
9 years
Incorporated 18 April 2016
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 1 May 2025 (6 months ago)
Next confirmation dated 1 May 2026
Due by 15 May 2026 (6 months remaining)
Last change occurred 1 year 6 months ago
Accounts
Submitted
For period 1 May30 Apr 2025 (12 months)
Accounts type is Micro Entity
Next accounts for period 30 April 2026
Due by 31 January 2027 (1 year 2 months remaining)
Address
C/O Flb Accountants Llp 1010 Eskdale Road
Winnersh Triangle
Wokingham
RG41 5TS
United Kingdom
Address changed on 23 Jan 2024 (1 year 9 months ago)
Previous address was Cawley House 149-155 Canal Street Nottingham Nottinghamshire NG1 7HR United Kingdom
Telephone
Unreported
Email
Unreported
People
Officers
3
Shareholders
2
Controllers (PSC)
2
Director • British • Lives in UK • Born in Jun 1985
Director • Turkish • Lives in Turkey • Born in Sep 1959
Director • Turkish • Lives in Turkey • Born in Mar 1964
Mr Kiren Lee Naidoo
PSC • British • Lives in UK • Born in Jun 1985
Mr Mehmet Levent Selamoglu
PSC • Turkish • Lives in Turkey • Born in Sep 1959
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Frontier Pharma Advisors Limited
Kiren Lee Naidoo is a mutual person.
Active
Frontier Biopharma Limited
Kiren Lee Naidoo is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
30 Apr 2024
For period 30 Apr30 Apr 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£865.96K
Same as previous period
Total Liabilities
-£90.64K
Increased by £3.82K (+4%)
Net Assets
£775.33K
Decreased by £3.82K (-0%)
Debt Ratio (%)
10%
Increased by 0.44% (+4%)
Latest Activity
Micro Accounts Submitted
12 Days Ago on 31 Oct 2025
Confirmation Submitted
6 Months Ago on 6 May 2025
Micro Accounts Submitted
1 Year 3 Months Ago on 29 Jul 2024
Mr Kiren Lee Naidoo (PSC) Details Changed
1 Year 3 Months Ago on 26 Jul 2024
Confirmation Submitted
1 Year 6 Months Ago on 13 May 2024
Mr Kiren Lee Naidoo Details Changed
1 Year 9 Months Ago on 23 Jan 2024
Mrs Esra Selamoglu Details Changed
1 Year 9 Months Ago on 23 Jan 2024
Mr Kiren Lee Naidoo (PSC) Details Changed
1 Year 9 Months Ago on 23 Jan 2024
Mr Mehmet Levent Selamoglu Details Changed
1 Year 9 Months Ago on 23 Jan 2024
Mehmet Levent Selamoglu (PSC) Appointed
7 Years Ago on 1 Jul 2018
Get Credit Report
Discover Frontier Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Micro company accounts made up to 30 April 2025
Submitted on 31 Oct 2025
Confirmation statement made on 1 May 2025 with no updates
Submitted on 6 May 2025
Micro company accounts made up to 30 April 2024
Submitted on 29 Jul 2024
Change of details for Mr Kiren Lee Naidoo as a person with significant control on 26 July 2024
Submitted on 29 Jul 2024
Notification of Mehmet Levent Selamoglu as a person with significant control on 1 July 2018
Submitted on 29 Jul 2024
Confirmation statement made on 1 May 2024 with updates
Submitted on 13 May 2024
Director's details changed for Mr Mehmet Levent Selamoglu on 23 January 2024
Submitted on 13 May 2024
Change of details for Mr Kiren Lee Naidoo as a person with significant control on 23 January 2024
Submitted on 13 May 2024
Director's details changed for Mrs Esra Selamoglu on 23 January 2024
Submitted on 13 May 2024
Director's details changed for Mr Kiren Lee Naidoo on 23 January 2024
Submitted on 13 May 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year